Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma.
Wei WangRui ZhangNing FengLongzhen ZhangNianli LiuPublished in: Journal of clinical and translational hepatology (2022)
Our study suggests that RBM34 may serve as a new prognostic marker and therapeutic target of HCC.